These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 28857533)
1. [Prophylactic thyroidectomy in RET proto-oncogen mutation]. Rodríguez Caraballo L; Gómez-Chacón Villalba J; Rodríguez Iglesias P; Cortés Sáez J; Moreno Macián F; Marco Macián A; Vila Carbó JJ Cir Pediatr; 2017 Apr; 30(2):100-104. PubMed ID: 28857533 [TBL] [Abstract][Full Text] [Related]
2. Role of preoperative basal calcitonin levels in the timing of prophylactic thyroidectomy in patients with germline RET mutations. Lifante JC; Blanchard C; Mirallié E; David A; Peix JL World J Surg; 2014 Mar; 38(3):576-81. PubMed ID: 24357249 [TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of prophylactic thyroidectomy in children carrying RET germline mutations. Machens A; Elwerr M; Lorenz K; Weber F; Dralle H Br J Surg; 2018 Jan; 105(2):e150-e157. PubMed ID: 29341155 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: A long-term follow-up in a large single-center cohort. Febrero B; Rodríguez JM; Ríos A; Segura P; Pérez-Sánchez B; Torregrosa N; Hernández AM; Parrilla P Eur J Surg Oncol; 2019 Apr; 45(4):625-630. PubMed ID: 30366876 [TBL] [Abstract][Full Text] [Related]
6. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature]. de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023 [TBL] [Abstract][Full Text] [Related]
8. The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center. Elisei R; Romei C; Renzini G; Bottici V; Cosci B; Molinaro E; Agate L; Cappagli V; Miccoli P; Berti P; Faviana P; Ugolini C; Basolo F; Vitti P; Pinchera A J Clin Endocrinol Metab; 2012 Feb; 97(2):426-35. PubMed ID: 22162466 [TBL] [Abstract][Full Text] [Related]
9. [Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree]. Zhao JQ; Guo L; Qi XP; Chen ZG; Wang KJ; Lou JL; Yu XH; Cheng J; Jin HY; Li XL; Ying RB; Zhang XN Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(6):440-4. PubMed ID: 23660264 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic thyroidectomies in MEN2 syndrome: Management and outcomes. Bussières V; Roy S; Deladoey J; Rousseau É; St-Vil D; Piché N J Pediatr Surg; 2018 Feb; 53(2):283-285. PubMed ID: 29336779 [TBL] [Abstract][Full Text] [Related]
12. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma. Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880 [TBL] [Abstract][Full Text] [Related]
13. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation? Calva D; O'Dorisio TM; Sue O'Dorisio M; Lal G; Sugg S; Weigel RJ; Howe JR Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011 [TBL] [Abstract][Full Text] [Related]
14. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour. Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610 [TBL] [Abstract][Full Text] [Related]
15. [Prophylactic thyroidectomy in children and young people with hereditary medullary thyroid carcinoma: a Chilean experience]. Ramos C; Ojeda D; Cohn D; Wohllk N Rev Med Chil; 2005 Sep; 133(9):1029-36. PubMed ID: 16311694 [TBL] [Abstract][Full Text] [Related]
16. Prophylactic thyroidectomy in MEN 2A syndrome: experience in a single center. Rodríguez GJ; Balsalobre MD; Pomares F; Torregrosa NM; Ríos A; Carbonell P; Glower G; Sola J; Tébar J; Parrilla P J Am Coll Surg; 2002 Aug; 195(2):159-66. PubMed ID: 12168961 [TBL] [Abstract][Full Text] [Related]
17. A Case of medullary thyroid carcinoma with de novo V804M RET germline mutation. Choi YS; Kwon HJ; Kim BK; Kwon SK; Park YH; Kim JH; Jung SB; Lee CH; Lee SK; Uchino S J Korean Med Sci; 2013 Jan; 28(1):156-9. PubMed ID: 23341727 [TBL] [Abstract][Full Text] [Related]
19. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers. Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218 [TBL] [Abstract][Full Text] [Related]
20. Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. Frank-Raue K; Buhr H; Dralle H; Klar E; Senninger N; Weber T; Rondot S; Höppner W; Raue F Eur J Endocrinol; 2006 Aug; 155(2):229-36. PubMed ID: 16868135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]